Corresponding to the stages in ESCC progression, TP53 mutation displayed positive impacts on DNA replication/cell cycle in the IEN phase, and ECM signaling in the A-ESCC phase (Supplementary Fig. 4l). This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.